Englewood, Colorado headquartered Gevo Inc.'s shares slid 0.46%, closing Wednesday's trading session at $0.41. The stock recorded a trading volume of 2.97 million shares. Shares of the Company are trading 7.34% below their 200-day moving average. Additionally, share of Gevo, which focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks, have a Relative Strength Index (RSI) of 37.28.
On October 11th, 2016, Gevo announced that it has completed production of the world's first cellulosic renewable jet fuel that is specified for commercial flights. Gevo successfully adapted its patented technologies to convert cellulosic sugars derived from wood waste into renewable isobutanol, which was then further converted into Gevo's Alcohol-to-Jet fuel (ATJ) fuel. This ATJ meets the ASTM D7566 specification allowing it to be used for commercial flights. Visit us today and download your complete report on GEVO for free at: http://stock-callers.com/registration/?symbol=GEVO
On Wednesday, shares in Midland, Michigan headquartered The Dow Chemical Co. recorded a trading volume of 6.46 million shares, which was above their three months average volume of 5.63 million shares. The stock declined 0.65%, ending the day at $53.76. The Company's shares have advanced 3.17% in the last month, 1.05% in the previous three months, and 7.29% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 1.62% and 7.01%, respectively. Furthermore, shares of Dow Chemical, which manufactures and supplies products that are used primarily as raw materials in the manufacture of customer products and services worldwide, have an RSI of 54.43.
On October 03rd, 2016, Monsanto Co. and Dow AgroSciences LLC, a wholly-owned subsidiary of Dow Chemical, announced that the companies have reached a non-exclusive global option and licensing agreement on Dow AgroSciences' EXZACT™ Precision Technology® Platform for research and commercial development of new crop solutions across Monsanto's research portfolio.
On October 10th, 2016, research firm UBS upgraded the Company's stock rating from 'Neutral' to 'Buy'. The research firm also revised upwards its previous target price from $53 to $62. The complimentary research report on DOW can be accessed at: http://stock-callers.com/registration/?symbol=DOW
The Woodlands, Texas headquartered Huntsman Corp.'s stock finished the day 1.97% higher at $16.56 and with a total trading volume of 2.22 million shares. The Company's shares have gained 6.63% in the last one month, 5.26% over the previous three months, and 49.56% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 2.32% and 19.73%, respectively. Additionally, shares of Huntsman, which together with its subsidiaries, manufactures and sells differentiated organic and inorganic chemical products worldwide, have an RSI of 53.48.
On October 25th, 2016, Huntsman announced global price increases for all its titanium dioxide pigments. The following increases are effective January 1st, 2017, or as contracts allow. Europe: €150 (Euros) per tonne, or $160 (USD) per tonne. Asia/Pacific, Africa, Latin America, and Middle East: $160 (USD) per tonne. North America: $0.07 per pound (USD). Register for free on Stock-Callers.com and download the PDF research report on HUN at: http://stock-callers.com/registration/?symbol=HUN
Shares in Irving, Texas headquartered Celanese Corp. ended yesterday's session 0.84% lower at $71.17. The stock recorded a trading volume of 824,679 shares. The Company's shares have advanced 11.62% in the last one month, 7.54% in the previous three months, and 7.39%, respectively. The stock is trading 9.23% above its 50-day moving average and 8.71% above its 200-day moving average. Moreover, shares of Celanese, which manufactures and sells value-added chemicals, thermoplastic polymers, and other chemical-based products worldwide, have an RSI of 66.67.
On October 07th, 2016, research firm KeyBanc Capital Markets initiated an 'Overweight' rating on the Company's stock, issuing a target price of $80 per share.
On October 26th, 2016, Celanese announced it has filed a complaint with the US International Trade Commission (ITC) in Washington, D.C., seeking an investigation of the unlawful importation into the US of artificial sweetener Acesulfame Potassium (Ace-K) products that infringe upon US Patent No. 9,024,016 owned by Celanese. Celanese contends a number of Ace-K manufacturers have unlawfully introduced sweeteners made via Celanese's patented technology from China into the US market. These manufacturers have been notified of their infringement of the asserted patent by the filing of this complaint with the ITC. Get free access to your research report on CE at: http://stock-callers.com/registration/?symbol=CE
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://stock-callers.com/legal-disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA